TETANUS IMMUNE GLOBULIN (HUMAN)

TETANUS IMMUNE GLOBULIN (HUMAN) was reported 109 times

TETANUS IMMUNE GLOBULIN (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTI-HUMAN ANTIBODY TEST 4 0.1481
1 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 16 0.0476
2 EPILEPSY WITH MYOCLONIC-ATONIC SEIZURES 1 0.0357
3 SHORT STATURE 8 0.0305
4 BODY HEIGHT BELOW NORMAL 16 0.0249
5 BONE DENSITY INCREASED 8 0.0201
6 ANTIBODY TEST POSITIVE 16 0.0096
7 DRUG SPECIFIC ANTIBODY 12 0.0088
8 CHEYNE-STOKES RESPIRATION 2 0.0081
9 JUVENILE IDIOPATHIC ARTHRITIS 16 0.0065
10 JOINT DESTRUCTION 7 0.0045
11 WHEELCHAIR USER 14 0.0031
12 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 7 0.0030
13 POLYARTHRITIS 16 0.0030
14 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
15 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
16 HYPERMAGNESAEMIA 1 0.0015
17 RED BLOOD CELL SEDIMENTATION RATE INCREASED 16 0.0014
18 PNEUMONIA ASPIRATION 33 0.0013
19 ADRENAL INSUFFICIENCY 16 0.0013
20 GRIMACING 1 0.0013
21 JOINT EFFUSION 8 0.0012
22 PRURIGO 1 0.0011
23 BONE DENSITY ABNORMAL 4 0.0011
24 EXPIRED DRUG ADMINISTERED 5 0.0010
25 OBESITY 16 0.0010
26 CAROTID ARTERIOSCLEROSIS 1 0.0010
27 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
28 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
29 CARDIAC HYPERTROPHY 1 0.0009
30 SYNOVITIS 16 0.0009
31 DYSMORPHISM 2 0.0008
32 SINUS ARRHYTHMIA 1 0.0008
33 COMA 35 0.0007
34 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
35 MENINGITIS BACTERIAL 1 0.0007
36 SINUS ARREST 1 0.0006
37 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
38 SKULL FRACTURE 1 0.0006
39 QUALITY OF LIFE DECREASED 8 0.0006
40 PUPIL FIXED 1 0.0006
41 HYPOPITUITARISM 1 0.0006
42 IMMUNODEFICIENCY 8 0.0005
43 IMPAIRED QUALITY OF LIFE 7 0.0005
44 BODY TEMPERATURE FLUCTUATION 1 0.0005
45 DRUG SPECIFIC ANTIBODY PRESENT 3 0.0005
46 CHOLESTATIC LIVER INJURY 1 0.0004
47 BONE DENSITY DECREASED 14 0.0004
48 GASTROENTERITIS VIRAL 8 0.0004
49 C-REACTIVE PROTEIN INCREASED 16 0.0004
50 UNDERDOSE 32 0.0004
51 NEUROLOGICAL DECOMPENSATION 1 0.0004
52 HYPOCALCAEMIA 8 0.0004
53 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
54 DIABETES INSIPIDUS 1 0.0004
55 RETINAL ARTERY OCCLUSION 1 0.0004
56 TRISMUS 2 0.0004
57 AREFLEXIA 1 0.0004
58 JOINT INJURY 8 0.0004
59 SEPTIC SHOCK 16 0.0004
60 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
61 PRESCRIBED UNDERDOSE 7 0.0004
62 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
63 HYPERCAPNIA 1 0.0003
64 ARTHROPATHY 15 0.0003
65 LIVER FUNCTION TEST ABNORMAL 7 0.0002
66 SHOULDER OPERATION 1 0.0002
67 SUSPECTED OFF LABEL USE 1 0.0002
68 ARTHRITIS 17 0.0002
69 THERAPY NON-RESPONDER 9 0.0002
70 MOBILITY DECREASED 14 0.0002
71 POOR VENOUS ACCESS 2 0.0002
72 NEUTROPHILIA 1 0.0002
73 HYPOKALAEMIA 8 0.0002
74 SOMNOLENCE 34 0.0002
75 DRUG INTOLERANCE 16 0.0002
76 BLEPHAROSPASM 1 0.0002
77 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
78 ASPERGILLUS INFECTION 1 0.0002
79 MENINGITIS 1 0.0001
80 PLEURAL EFFUSION 8 0.0001
81 HYPERTHERMIA 1 0.0001
82 CONCUSSION 1 0.0001
83 PSORIASIS 16 0.0001
84 ENCEPHALOPATHY 3 0.0001
85 PSEUDOMONAS INFECTION 1 0.0001
86 SYRINGE ISSUE 2 0.0001
87 SPINAL OSTEOARTHRITIS 1 0.0001
88 WRONG DRUG ADMINISTERED 1 0.0001
89 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
90 PNEUMONIA BACTERIAL 1 0.0001
91 PRODUCT PACKAGING ISSUE 1 0.0001
92 DISABILITY 2 0.0001
93 HELICOBACTER INFECTION 1 0.0001
94 RASH MACULO-PAPULAR 2 0.0001
95 INJECTION SITE DISCOLOURATION 1 0.0001
96 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
97 HIATUS HERNIA 1 0.0001
98 RESPIRATORY DISORDER 2 0.0001
99 ULCER 1 0.0001
100 LOSS OF CONSCIOUSNESS 8 0.0001
101 RHEUMATOID ARTHRITIS 7 0.0001
102 CONDITION AGGRAVATED 18 0.0001
103 EOSINOPHILIA 1 0.0001
104 DRUG ERUPTION 1 0.0001
105 ANAPHYLACTIC REACTION 3 0.0001
106 GASTRIC ULCER 1 0.0001
107 HYPOTENSION 10 0.0000
108 PRODUCT USE ISSUE 9 0.0000
109 SKIN CANCER 1 0.0000
110 HYPOGLYCAEMIA 2 0.0000
111 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
112 ANAPHYLACTIC SHOCK 1 0.0000
113 VOMITING 18 0.0000
114 GASTRITIS 1 0.0000
115 OFF LABEL USE 33 0.0000
116 LIMB INJURY 1 0.0000
117 RESPIRATORY ARREST 1 0.0000
118 MENTAL STATUS CHANGES 1 0.0000
119 NEEDLE ISSUE 1 0.0000
120 TACHYCARDIA 3 0.0000
121 DRUG ADMINISTRATION ERROR 1 0.0000
122 NERVOUS SYSTEM DISORDER 1 0.0000
123 SWOLLEN TONGUE 1 0.0000
124 EYE DISORDER 1 0.0000
125 DIZZINESS 15 0.0000
126 PYREXIA 10 0.0000
127 HYPOXIA 1 0.0000
128 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
129 DIARRHOEA 17 0.0000
130 ANGIOEDEMA 1 0.0000
131 COLITIS ULCERATIVE 1 0.0000
132 DRUG INEFFECTIVE 29 0.0000
133 PRODUCTIVE COUGH 1 0.0000
134 ATRIAL FIBRILLATION 2 0.0000
135 ARTHRALGIA 8 0.0000
136 MUSCULOSKELETAL PAIN 1 0.0000
137 HYPERTENSION 4 0.0000
138 OXYGEN SATURATION DECREASED 1 0.0000
139 NAUSEA 14 0.0000
140 CONVULSION 1 0.0000
141 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
142 UNEVALUABLE EVENT 1 0.0000
143 INJECTION SITE HAEMORRHAGE 1 0.0000
144 DRY MOUTH 1 0.0000
145 INFLUENZA LIKE ILLNESS 1 0.0000
146 CEREBROVASCULAR ACCIDENT 2 0.0000
147 BALANCE DISORDER 1 0.0000
148 MUSCULOSKELETAL STIFFNESS 1 0.0000
149 MUSCLE SPASMS 2 0.0000
150 CARDIAC DISORDER 1 0.0000
151 DYSPHAGIA 1 0.0000
152 PULMONARY EMBOLISM 1 0.0000
153 SYNCOPE 1 0.0000
154 DISEASE PROGRESSION 1 0.0000
155 HYPERHIDROSIS 1 0.0000
156 PRODUCT QUALITY ISSUE 1 0.0000
157 VISION BLURRED 1 0.0000
158 DRUG INTERACTION 1 0.0000
159 CONFUSIONAL STATE 1 0.0000
160 URTICARIA 1 0.0000
161 NO ADVERSE EVENT 1 0.0000
162 PAIN 2 0.0000
163 FALL 1 0.0000
164 FATIGUE 1 0.0000